Conversely, in SU-R RCC cells, CYP1B1 depletion led to reduced levels of N-cadherin and vimentin and increased ZO-1 expression following sunitinib treatment (Fig. 3E and S3F). The gene discussed is CYP1B1; the disease is renal cell carcinoma.